WallStreetZenWallStreetZen

NASDAQ: APGN
Apexigen Inc Stock

$0.55+0.01 (+1.85%)
Updated Jun 1, 2023
APGN Price
$0.55
Fair Value Price
$748.61
Market Cap
$13.56M
52 Week Low
$0.33
52 Week High
$31.35
P/E
-0.47x
P/B
4.36x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$29.08M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
4.65
Operating Cash Flow
-$29M
Beta
0.51
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

APGN Overview

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how APGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

APGN ($0.55) is undervalued by 99.93% relative to our estimate of its Fair Value price of $748.61 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
APGN ($0.55) is significantly undervalued by 99.93% relative to our estimate of its Fair Value price of $748.61 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
APGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more APGN due diligence checks available for Premium users.

Be the first to know about important APGN news, forecast changes, insider trades & much more!

APGN News

Valuation

APGN fair value

Fair Value of APGN stock based on Discounted Cash Flow (DCF)
Price
$0.55
Fair Value
$748.61
Undervalued by
99.93%
APGN ($0.55) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
APGN ($0.55) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
APGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

APGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.47x
Industry
11.46x
Market
52.37x

APGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.36x
Industry
5.14x
APGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

APGN's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.1M
Profit Margin
0%
APGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$17.6M
Liabilities
$14.5M
Debt to equity
4.65
APGN's short-term assets ($16.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
APGN's short-term assets ($16.63M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
APGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.8M
Investing
$2.2M
Financing
$2.5M
APGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

APGN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
APGN$13.56M+2.61%-0.47x4.36x
ACGN$13.56M+3.21%-0.22x1.15x
AEZS$13.50M+0.18%-0.55x0.43x
ACOR$13.48M-7.67%-0.21x0.18x
APRE$13.66M-4.94%-0.05x0.52x

Apexigen Stock FAQ

What is Apexigen's quote symbol?

(NASDAQ: APGN) Apexigen trades on the NASDAQ under the ticker symbol APGN. Apexigen stock quotes can also be displayed as NASDAQ: APGN.

If you're new to stock investing, here's how to buy Apexigen stock.

What is the 52 week high and low for Apexigen (NASDAQ: APGN)?

(NASDAQ: APGN) Apexigen's 52-week high was $31.35, and its 52-week low was $0.33. It is currently -98.25% from its 52-week high and 66.16% from its 52-week low.

How much is Apexigen stock worth today?

(NASDAQ: APGN) Apexigen currently has 24,660,587 outstanding shares. With Apexigen stock trading at $0.55 per share, the total value of Apexigen stock (market capitalization) is $13.56M.

Apexigen stock was originally listed at a price of $10.23 in Jan 29, 2021. If you had invested in Apexigen stock at $10.23, your return over the last 2 years would have been -94.62%, for an annualized return of -76.81% (not including any dividends or dividend reinvestments).

How much is Apexigen's stock price per share?

(NASDAQ: APGN) Apexigen stock price per share is $0.55 today (as of Jun 1, 2023).

What is Apexigen's Market Cap?

(NASDAQ: APGN) Apexigen's market cap is $13.56M, as of Jun 3, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Apexigen's market cap is calculated by multiplying APGN's current stock price of $0.55 by APGN's total outstanding shares of 24,660,587.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.